Sanofi (SNY)
(Delayed Data from NSDQ)
$49.36 USD
+2.75 (5.90%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $49.31 -0.05 (-0.10%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum B VGM
Average Brokerage Rating
Current ABR | 1.71 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 14 |
Average Target Price | $60.90 |
LT Growth Rate | 8.10% |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 211 of 252 |
Current Quarter EPS Est: | 0.96 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 9 | 9 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 4 | 4 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.71 | 1.86 | 1.86 | 1.83 | 1.83 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/8/2024 | Argus Research Corp. | Jasper Hellweg | Strong Buy | Strong Buy |
2/5/2024 | SVB Securities | David Risinger | Strong Buy | Strong Buy |
9/5/2023 | Berenberg Bank | Luisa Hector | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.